Kazuistika pacienta se značně pokročilým a diseminovaným karcinomem žaludku léčeným preparátem S-1

Title in English Case Report of a Patient with Advanced and Disseminated Gastric Carcinoma Treated by S-1
Authors

KATOLICKÁ Jana ROTNÁGLOVÁ Simona VANÍČEK Jiří

Year of publication 2014
Type Article in Periodical
Magazine / Source Klinická onkologie
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords case report; metastatic gastric cancer; chemotherapy ; S-1-cisplatin
Description Background: Prognosis of patients with metastatic gastric cancer is abysmal, usually just a few months. S-1 is a peroral fl uoropyrimidine antitumor drug. It is a fi xed combination of three eff ective drugs – tegafur, gimeracil and oteracil potassium. Case: This is a case report of a 71-year-old man treated for local advanced and metastatic gastric carcinoma treated with combination of S-1 and cisplatin as a fi rst line of therapy. Treatment response reached partial remission and lasted for six months. Treatment was very well tolerated, with no grade 3 and 4 toxicity. After progression, the patient was treated with further lines of therapy. Conclusion: In the Czech Republic, experience with S-1 drug is very limited. Our case report showed a good treatment response and minimal toxicity of this treatment, in concordance with results of the study FLAGS.

You are running an old browser version. We recommend updating your browser to its latest version.

More info